ask="1.8800"
ask_size="1000"
average_daily_volume="718990"
bid="1.7300"
bid_size="100"
book_value="1.0670"
change="-0.0099"
change_from_200_day_moving_average="-0.3988"
change_from_50_day_moving_average="0.2629"
change_from_52_week_high="-4.0279"
change_From_52_week_low="1.7296"
change_in_percent="-0.5657%"
close="1.7401"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.0060"
ebitda="-16.58M"
eps_estimate_current_year="-0.9200"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.2800"
ex_dividend_date="N/A"
float_shares="5773000"
high="1.8700"
high_52_weeks="5.7680"
last_trade_date="2/3/2017"
last_trade_price="1.7401"
last_trade_size="100"
last_trade_time="3:59pm"
low="1.6021"
low_52_weeks="0.0105"
market_capitalization="20.34M"
moving_average_200_day="2.1389"
moving_average_50_day="1.4772"
name="PhaseRx
Inc."
notes="N/A"
one_year_target_price="10.0000"
open="1.7500"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-18.6436%"
percent_change_from_50_day_moving_average="+17.7948%"
percent_change_from_52_week_high="-69.8318%"
percent_change_from_52_week_low="+16472.3809%"
previous_close="1.7500"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.6401"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="11690000"
short_ratio="0.0400"
stock_exchange="NCM"
symbol="PZRX"
volume="382548"
weeks_range_52="0.0105 - 5.7680"
